Placebo Controlled Study to Assess the Effect of Roflumilast in Hyperinflated COPD Patients in Addition to LABA/LAMA Therapy Using Functional Respiratory Imaging.
Phase of Trial: Phase II
Latest Information Update: 22 Mar 2018
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors FLUIDDA
- 19 Mar 2018 Status changed from recruiting to discontinued.
- 02 Oct 2017 Planned End Date changed from 1 Aug 2017 to 1 Jan 2018.
- 02 Oct 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2017.